UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) [ ☒ ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or [ ☐ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-08052 GLOBE LIFE INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation o ...

Market Overview - The broader equity markets experienced a recovery after a significant sell-off, particularly driven by technology stocks like NVIDIA and Broadcom [1] - Bitcoin rebounded after dropping to $60,062.00, indicating a shift in investor sentiment towards risk-off strategies [1][2] Financial Sector Insights - The finance sector faces latent threats from AI and disappointing retail sales data, contributing to market volatility [2] - Investors are adopting a "wait-and-see" approach, focusing on "cash cow" stocks that offer higher returns [2] Key Financial Metrics - Return on Equity (ROE) is highlighted as a crucial metric for assessing a company's profitability and financial health [3][4] - A high ROE indicates effective reinvestment of cash at high rates of return, distinguishing profit-generating companies from less efficient ones [3][4] Stock Screening Criteria - Stocks are screened based on parameters such as Cash Flow greater than $1 billion and ROE exceeding industry averages [5] - Additional criteria include Price/Cash Flow lower than industry averages and Return on Assets (ROA) greater than industry benchmarks [6] Selected Stocks - Alcoa Corporation (AA): Engaged in mining and electricity generation, with a trailing four-quarter earnings surprise of 44.5% and a Zacks Rank 1 [7][8] - Globe Life Inc. (GL): An insurance holding company with a Zacks Rank 2 and a focus on life and supplemental health insurance [9][10] - Banco Bilbao Vizcaya Argentaria, S.A. (BBVA): Provides banking and asset management services, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [10][11] - The TJX Companies, Inc. (TJX): A leading off-price retailer with a long-term earnings growth expectation of 10.2% and a Zacks Rank 2 [12][13] - TE Connectivity plc (TEL): A global technology company focused on connectivity solutions, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [14][15]

Core Viewpoint - Globe Life Inc. (GL) has shown strong performance in the life and health insurance sector, with a market cap of $11.3 billion and a focus on lower middle- and middle-income families [1]. Financial Performance - In Q4 2025, Globe Life reported adjusted EPS of $3.39 and revenue of $1.52 billion, which were weaker than expected; however, shares rose 1.5% the following day due to strong year-over-year gains [4]. - For the fiscal year ending December 2026, analysts expect GL's adjusted EPS to grow 4.1% year-over-year to $15.12 [5]. Stock Performance - Over the past 52 weeks, GL stock has increased by 16.1%, outperforming the S&P 500 Index's 14.4% gain [2]. - Year-to-date, GL stock is up 1.5%, slightly ahead of the S&P 500's 1.4% gain [2]. Analyst Ratings - Among 14 analysts covering Globe Life, the consensus rating is a "Moderate Buy," with eight "Strong Buys," one "Moderate Buy," and five "Holds" [5]. - J.P. Morgan's Jimmy Bhullar reaffirmed a "Buy" rating with a price target of $181, while the mean price target of $169.50 suggests a 19.4% premium to current levels [6].

Core Viewpoint - Globe Life (GL) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the importance of changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. Company Performance and Investor Sentiment - The upgrade reflects an improvement in Globe Life's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - Over the past three months, the Zacks Consensus Estimate for Globe Life has increased by 0.6%, indicating a positive trend in earnings expectations [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - Globe Life's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Globe Life Inc. is recognized as one of the 10 Most Profitable Undervalued Stocks to Buy, with a price target raised to $181 by JPMorgan analyst Jimmy Bhullar, reflecting a positive outlook on the company's earnings potential [1][6]. Financial Performance - For the fourth quarter, Globe Life Inc. reported revenue of $1.52 billion, slightly below the consensus estimate of $1.53 billion, indicating a minor shortfall in top-line performance [2]. - The company projects earnings for fiscal year 2026 to be between $14.95 and $15.65 per share, surpassing the consensus estimate of $15.03, suggesting management's confidence in continued earnings growth [2]. Business Overview - Globe Life Inc. specializes in providing life and supplemental health insurance products primarily targeting lower-middle- and middle-income households in the United States [3]. - The company operates through various subsidiaries, offering a diverse range of products including whole and term life policies, Medicare supplements, and limited-benefit health products such as accident, cancer, and critical illness coverage [3].

Financial Data and Key Metrics Changes - In Q4, net income was $266 million or $3.29 per share, compared to $255 million or $3.01 per share a year ago, representing a year-over-year increase [4] - Net operating income for the quarter was $274 million, or $3.39 per share, an increase of 8% over the $3.14 per share from a year ago [4] - For the full year 2025, net operating income was $14.52, 2 cents above the midpoint of previous guidance [4] - Return on equity through December 31 was 20.9%, and book value per share was $74.17 [4][5] - Excluding accumulated other comprehensive income, return on equity is 16%, and book value per share as of December 31 is $96.16, up 11% from a year ago [5] Business Line Data and Key Metrics Changes - Total premium revenue in Q4 grew 5% over the year-ago quarter [7] - Life premium revenue for Q4 increased 3% from the year-ago quarter to $850 million [7] - Life underwriting margin was $350 million, up 4% from a year ago [8] - Health premium revenue grew 9% to $392 million, with health underwriting margin also up 9% to $99 million [8] - Administrative expenses were $92 million for the quarter, an increase of approximately 1% over the fourth quarter of 2024 [9] Market Data and Key Metrics Changes - In 2026, life premium revenue is expected to grow between 4% and 4.5%, while health premium revenue is expected to grow in the range of 14%-16% [8][18] - The average producing agent count trends for 2026 are projected as follows: American Income, mid-single-digit growth; Liberty National, high single-digit growth; Family Heritage, low double-digit growth [18] Company Strategy and Development Direction - The company focuses on providing financial security in the underserved lower-middle to middle-income market, which has significant growth opportunities [5][6] - The business model is designed to distribute basic protection products that are simple for agents and consumers to understand [5] - The company aims to maintain capital within its insurance operations at levels necessary to support current ratings, targeting a consolidated company action level RBC ratio in the range of 300%-320% [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model and its ability to continue growing, citing favorable mortality trends and premium growth [6][39] - For 2026, the company estimates net operating earnings per diluted share will be in the range of $14.95-$15.65, representing 5% earnings per share growth at the midpoint of the range [39] - The company anticipates total premium revenue growth of 7%-8% for 2026, with specific growth expectations for life and health premiums [40] Other Important Information - The company repurchased approximately 1.3 million shares for a total cost of approximately $170 million in Q4 [30] - The parent company began the year with liquid assets of approximately $90 million and ended the year with approximately $80 million [30] - The company finalized the licensing and formation of Globe Life Re Ltd, a Bermuda reinsurance affiliate, to reinsure a portion of new business and in-force life insurance policies [35] Q&A Session Summary Question: First-year lapses across various channels - Management acknowledged that first-year lapses for direct-to-consumer and Liberty National were higher than expected, attributing it to fluctuations and monitoring the situation closely [46] Question: Dynamics between MedSup and Med Advantage - Management noted that claim trends have stabilized and rate increases are expected to bring margins back to normal levels [49][50] Question: Sales growth and efficiencies - Management indicated that technology investments will continue to drive efficiencies and sales growth, with more enhancements expected in the coming years [58][60] Question: Remeasurement gains - Management explained that favorable mortality and lapse experience are driving remeasurement gains, with expectations for continued gains in the future [63] Question: Excess cash flow and GAAP vs statutory differences - Management clarified that excess cash flow guidance remains consistent, driven by solid statutory earnings and dividends to the parent company [68][71] Question: American Income agent count drop - Management stated that a drop in agent count is not uncommon in Q4 and discussed initiatives to improve agent retention [73]

Financial Data and Key Metrics Changes - In Q4, net income was $266 million or $3.29 per share, compared to $255 million or $3.01 per share a year ago, representing a year-over-year increase [4] - Net operating income for the quarter was $274 million, or $3.39 per share, an increase of 8% over the $3.14 per share from a year ago [4] - For the full year 2025, net operating income was $14.52, 2 cents above the midpoint of previous guidance [4] - Return on equity through December 31 was 20.9%, and book value per share was $74.17 [4][5] - Excluding accumulated other comprehensive income, return on equity was 16%, and book value per share as of December 31 was $96.16, up 11% from a year ago [5] Business Line Data and Key Metrics Changes - Total premium revenue in Q4 grew 5% over the year-ago quarter [7] - Life premium revenue for Q4 increased 3% from the year-ago quarter to $850 million, with life underwriting margin up 4% to $350 million [7][8] - Health insurance premium revenue grew 9% to $392 million, with health underwriting margin also up 9% to $99 million [8] - Administrative expenses were $92 million for the quarter, an increase of approximately 1% over the fourth quarter of 2024 [9] Market Data and Key Metrics Changes - The company expects total premium revenue to grow approximately 7% to 8% for the full year 2026 [7] - Life premium revenue is expected to grow between 4% and 4.5% in 2026, while health premium revenue is expected to grow in the range of 14% to 16% [8][40] Company Strategy and Development Direction - The company focuses on providing financial security in the underserved lower-middle to middle-income market, which has significant growth opportunities [5][6] - The business model is designed to distribute basic protection products that are simple for agents and consumers to understand [5] - The company aims to maintain capital within its insurance operations at levels necessary to support current ratings, targeting a consolidated company action level RBC ratio in the range of 300% to 320% [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model's effectiveness for future success and highlighted the significant sustainable growth opportunity [5][6] - The company anticipates continued favorable trends in mortality and experience, which are expected to positively impact future earnings [39] - Management expects normalized earnings per share growth of approximately 10% for 2026, with total premium revenue growth of 7% to 8% [39][40] Other Important Information - The company repurchased approximately 1.3 million shares for a total cost of approximately $170 million in Q4 [30] - The parent company anticipates excess cash flow to increase to approximately $625 million to $675 million in 2026 [32] Q&A Session Summary Question: First-year lapses across various channels - Management acknowledged that first-year lapses for direct-to-consumer and Liberty National were higher than expected, attributing it to fluctuations and monitoring the situation closely [46] Question: Dynamics between Medicare Supplement and Medicare Advantage - Management noted that claim trends have stabilized and that rate increases are expected to bring margins back to normal levels [49][50] Question: Sales growth and efficiencies - Management indicated that technology investments will continue to drive efficiencies and sales growth, with more enhancements expected in 2026 and 2027 [58][60] Question: Remeasurement gains - Management explained that favorable mortality and lapse experiences are driving remeasurement gains, with expectations for continued gains in the future [63] Question: Excess cash flow guidance - Management clarified that excess cash flow guidance remains consistent due to solid statutory earnings, with no significant changes impacting the statutory or GAAP models [68][71] Question: American Income agent count drop - Management stated that the drop in agent count is not uncommon for Q4 and is focusing on retention initiatives to improve productivity [73]

Financial Data and Key Metrics Changes - In Q4, net income was $266 million or $3.29 per share, compared to $255 million or $3.01 per share a year ago, representing a significant increase [3] - Net operating income for the quarter was $274 million, or $3.39 per share, an increase of 8% over the $3.14 per share from a year ago [3] - For the full year 2025, net operating income was $14.52, 2 cents above the midpoint of previous guidance [3] - Return on equity through December 31 is 20.9%, and book value per share is $74.17 [3] - Excluding accumulated other comprehensive income, return on equity is 16%, and book value per share as of December 31 is $96.16, up 11% from a year ago [4] Business Line Data and Key Metrics Changes - Total premium revenue in Q4 grew 5% over the year-ago quarter, with life premium revenue increasing 3% to $850 million [5][6] - Life underwriting margin was $350 million, up 4% from a year ago, driven by premium growth and lower overall policy obligations [6] - Health insurance premium revenue grew 9% to $392 million, with health underwriting margin also up 9% to $99 million [6] - For 2026, life premium revenue is expected to grow between 4% and 4.5%, while health premium revenue is projected to grow in the range of 14%-16% [6][37] Market Data and Key Metrics Changes - The company serves the underserved lower-middle to middle-income market, with over 50% of Americans being underinsured, indicating a significant growth opportunity [4] - The Medicare Supplement business is experiencing strong sales activity and premium rate increases, contributing to the growth in health premium revenue [6][15] Company Strategy and Development Direction - The company focuses on providing financial security in the underserved market, distributing basic protection products designed to meet the needs of this demographic [4] - The company aims to leverage technology investments to enhance agent productivity and sales growth [56] - The strategy includes maintaining pricing for profitability rather than chasing market share, ensuring long-term stability [82] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model and its ability to continue growing, citing favorable mortality trends and premium growth [5][36] - The company anticipates continued strong performance in the Medicare Supplement market due to dynamics in the Medicare Advantage space [48] - For 2026, the company expects net operating earnings per diluted share to be in the range of $14.95-$15.65, representing 5% growth at the midpoint [36] Other Important Information - The company repurchased approximately 1.3 million shares for a total cost of approximately $170 million in Q4 [28] - The parent company anticipates excess cash flow to increase to approximately $625 million-$675 million in 2026 [29] Q&A Session Summary Question: First-year lapses across various channels - Management acknowledged that first-year lapses were higher than expected, particularly in direct-to-consumer and Liberty National, but viewed it as fluctuations to monitor [41][42] Question: Dynamics between Medicare Supplement and Medicare Advantage - Management noted that claim trends have stabilized and rate increases are expected to restore margins to normal levels [43][44] Question: Sales growth and efficiency improvements - Management indicated that technology investments will continue to drive efficiency and sales growth, with more enhancements expected in 2026 and 2027 [54][56] Question: Remeasurement gains and their drivers - Management explained that favorable mortality and lapse experience are driving remeasurement gains, with expectations for continued gains in the future [59][60] Question: Excess cash flow guidance - Management clarified that excess cash flow guidance remains consistent due to solid statutory earnings, with no significant changes impacting the statutory or GAAP models [65][66] Question: American Income agent count drop - Management stated that a drop in agent count is not uncommon in Q4 and highlighted initiatives to improve agent retention [71][72]

分组1 - Globe Life reported quarterly earnings of $3.39 per share, missing the Zacks Consensus Estimate of $3.44 per share, but showing an increase from $3.14 per share a year ago, resulting in an earnings surprise of -1.31% [1] - The company posted revenues of $1.52 billion for the quarter ended December 2025, which was below the Zacks Consensus Estimate by 0.73%, and an increase from $1.46 billion year-over-year [2] - Over the last four quarters, Globe Life has surpassed consensus EPS estimates two times but has not beaten consensus revenue estimates [2] 分组2 - The stock has gained approximately 2.7% since the beginning of the year, outperforming the S&P 500's gain of 1.1% [3] - The current consensus EPS estimate for the coming quarter is $3.52 on revenues of $1.56 billion, and for the current fiscal year, it is $15.04 on revenues of $6.35 billion [7] - The Zacks Industry Rank for Insurance - Accident and Health is currently in the bottom 30% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Financial Performance - Net income for Q4 2025 was $3.29 per diluted common share, an increase of 9.3% from $3.01 in Q4 2024[2] - Net operating income for Q4 2025 was $3.39 per diluted common share, up 8% from $3.14 in Q4 2024[2] - For the full year 2025, net income was $14.07 per diluted common share, a rise of 17.8% from $11.94 in 2024[3] - Full year net operating income increased 17% to $14.52 per diluted common share from $12.37 in 2024[3] - Net income for Q4 2025 was $266,083,000, representing a 4.5% increase from $255,196,000 in Q4 2024[61] - Basic net income per common share for Q4 2025 was $3.35, up from $3.04 in Q4 2024, reflecting a 10.2% increase[61] - Total revenue for Q4 2025 was $1,519,621,000, compared to $1,466,277,000 in Q4 2024, marking an increase of 3.6%[61] Insurance Sales and Premiums - Life net sales at the American Income Life Division increased by 10% year-over-year, while life premiums rose by 6%[6] - Health net sales at the Family Heritage Division surged 15%, with premiums increasing by 10% compared to the previous year[6] - Total insurance premium revenue for Q4 2025 was $1.24 billion, a 5% increase from $1.18 billion in Q4 2024[20] - Total life premium for Q4 2025 reached $849.58 million, a 3% increase from $822.96 million in Q4 2024[28] - Life net sales for Q4 2025 were $161.15 million, reflecting an 11% increase compared to $144.93 million in Q4 2024[28] - Health premium for Q4 2025 was $392.34 million, a 9% increase from $358.31 million in Q4 2024[31] - Total health net sales for Q4 2025 were $125.79 million, a 71% increase from $73.64 million in Q4 2024[31] - Total premium revenue for the year ended December 31, 2025, was $4,890,220,000, a 4.8% increase compared to $4,666,272,000 in 2024[61] Investment and Expenses - Excess investment income for Q4 2025 was $30.81 million, down 20% from $38.33 million in Q4 2024[37] - The company reported a net investment income of $281,402,000 for Q4 2025, slightly down from $282,453,000 in Q4 2024[61] - The amortization of deferred acquisition costs for Q4 2025 was $116,770,000, compared to $104,298,000 in Q4 2024, indicating a 12% increase[61] - The ratio of administrative expenses to premium was 7.4%, down from 7.7% in the year-ago quarter[23] Shareholder Actions - The company repurchased 1.3 million shares at a total cost of $170 million during Q4 2025, with an average share price of $134.44[51] Future Projections - Globe Life projects net operating income for 2026 to be between $14.95 and $15.65 per diluted common share, an increase from previous guidance[53] Agent Performance - The average producing agent count at the Liberty National Division grew by 6% year-over-year[6] - The average producing agent count for American Income decreased by 2% to 11,699 in Q4 2025 compared to 11,926 in Q4 2024[33] Investment Portfolio - The investment portfolio at book value as of December 31, 2025, totaled $20.47 billion, with fixed maturities making up 86% of the total[41] - The company’s average invested assets increased by 1% while net investment income remained relatively flat[38] Realized Gains and Losses - The company experienced realized losses of $4,312,000 in Q4 2025, contrasting with realized gains of $2,392,000 in Q4 2024[61]